Neuropathic Clinical Trials

142 recruitingLast updated: July 25, 2026

There are 142 actively recruiting neuropathic clinical trials across 31 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 1, Phase 4. Top locations include Boston, Massachusetts, United States, Chicago, Illinois, United States, Miami, Florida, United States. Updated daily from ClinicalTrials.gov.


Neuropathic Trials at a Glance

142 actively recruiting trials for neuropathic are listed on ClinicalTrialsFinder across 6 cities in 31 countries. The largest study group is Not Applicable with 65 trials, with the heaviest enrollment activity in Boston, Chicago, and Miami. Lead sponsors running neuropathic studies include Afyonkarahisar Health Sciences University, Centre Hospitalier Universitaire de Saint Etienne, and Hospital Ambroise Paré Paris.

Browse neuropathic trials by phase

Treatments under study

About Neuropathic Clinical Trials

Looking for clinical trials for Neuropathic? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Neuropathic trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Neuropathic clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 142 trials

Recruiting
Phase 3

Mechanisms of Stimulation for Pain Alleviation

Chronic Neuropathic PainPeripheral Nerve StimulationChronic Neuropathic Pain (Below the Shoulders)
Stanford University148 enrolled2 locationsNCT06741579
Recruiting
Phase 3

Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy

Diabetic peripheral neuropathic pain
Vertex Pharmaceuticals Incorporated734 enrolled75 locationsNCT07231419
Recruiting
Phase 3

Extended-release Pregabalin for the Treatment of Neuropathic Pain in Patients With Diabetic Peripheral Neuropathy and Postherpetic Neuralgia

Neuropathic PainDiabetic NeuropathyNeuralgia, Postherpetic
Brainfarma Industria Química e Farmacêutica S/A348 enrolled15 locationsNCT07712913
Recruiting
Phase 1

Novel Soluble Epoxide Hydrolase Inhibitor for Neuropathic Pain in Patients With Spinal Cord Injury

Spinal StenosisDegenerative Disc DiseaseSpinal Cord Injuries+2 more
EicOsis Human Health Inc.36 enrolled1 locationNCT06438471
Recruiting
Phase 2

A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain

Diabetic peripheral neuropathic pain
Eli Lilly and Company150 enrolled37 locationsNCT07285018
Recruiting
Not Applicable

aiTBS and rTMS in Neuropathic Pain and Prediction of Response

Chronic Neuropathic Pain
Hospital Ambroise Paré Paris30 enrolled1 locationNCT07650526
Recruiting

Hematological Indices and Sympathetic Block Response in Neuropathic Pain

Neuropathic PainNeuropathic Pain Diagnostic Questionnaire (DN4) ≥ 4
Ankara City Hospital Bilkent120 enrolled1 locationNCT07596823
Recruiting

Study of the Location of Motor Cortical Stimulation Electrodes in Chronic Neuropathic Refractory Patients

Neuropathic Pain
Centre Hospitalier Universitaire de Nice100 enrolled1 locationNCT06216717
Recruiting
Not Applicable

Repetitive Transcranial Magnetic Stimulation Therapy in Spinal Cord Injury Related Neuropathic Pain

Spinal Cord InjuriesNeuropathic Pain
Afyonkarahisar Health Sciences University63 enrolled1 locationNCT06726954
Recruiting

The Prevalence of Neuropathic Pain Pathophysiology Associated With Ankle Fracture

Neuropathic Pain
Indiana University250 enrolled1 locationNCT06420141
Recruiting
Not Applicable

Neuropathic Dental Pain & DBS

Dental NeuralgiaNeuropathic Dental Pain
University of British Columbia5 enrolled1 locationNCT07671950
Recruiting
Not Applicable

Real-World Efficacy of Evoke® Closed-loop Spinal Cord Stimulation (CL-SCS) Therapy in Chronic Pain Patients (ULTRA).

PainChronic PainNeuropathic Pain
Saint Francis Hospital50 enrolled1 locationNCT06246526
Recruiting
Phase 2

A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain

diabetic neuropathic painChronic Low-back PainOsteoarthritis, Knee
Eli Lilly and Company10,000 enrolled64 locationsNCT05986292
Recruiting
Phase 2Phase 3

Virtual Menstrual Pain Approaches in Females

Digital HealthAcupressureMetabolomics+5 more
Nanyang Technological University145 enrolled1 locationNCT07497711
Recruiting
Phase 1

Safety, Tolerability, and Pharmacokinetics of ASCT-83 in Healthy Adults

Neuropathic Pain
Alcamena Stem Cell Therapeutics72 enrolled1 locationNCT07363395
Recruiting
Phase 3

Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

Diabetic peripheral neuropathic pain
Vertex Pharmaceuticals Incorporated1,100 enrolled76 locationsNCT06628908
Recruiting
Not Applicable

Chronic Unilateral Lumbar Radicular Pain

Neuropathic Pain
Ain Shams University80 enrolled1 locationNCT06092749
Recruiting
Phase 3

Analgesic Effectiveness of Capsaicin 8% Cutaneous Patch in Children

Chronic PainNeuropathic Pain
University Hospital, Brest46 enrolled10 locationsNCT05997979
Recruiting
Phase 3

Efficacy of an Intraoperative Periradicular Application of Platelet Rich Fibrin (PRF) on the Intensity of Residual Post-surgical Neuropathic Pain After a Surgery for Disc Herniation

Neuropathic PainChronic Postsurgical Pain
University Hospital, Strasbourg, France60 enrolled1 locationNCT05196503
Recruiting
Not Applicable

Evaluating Laser Photobiomodulation for the Treatment of Neuropathic Pain in Chemotherapy-induced Peripheral Neuropathy in Cancer Patients

Peripheral neuropathic painCancer Survivors
Institut du Cancer de Montpellier - Val d'Aurelle70 enrolled1 locationNCT06834685